** U.S.-listed shares of Israel-based medical technology firm InMode INMD.O fall 6% to $14.30 premarket

** INMD says a special committee of its board reviewed possible deal proposals but found none good enough

** The company says the committee has ended the process and will keep reviewing its business plans and use of cash

** Last month, Steel Partners offered $18 per share to acquire a 51% stake in InMode

** Earlier this month, co said it was evaluating potential strategic alternatives

** INMD fell 12% in 2025

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))